ArticleBritish journal of cancer2015

Phase I trial of EpCAM-targeting immunotoxin MOC31PE, alone and in combination with cyclosporin.

Y Andersson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.